Rare loss-of-function variants in ANGPTL3, also implicated in the lipoprotein lipase pathway, are associated with reduced LDL-C and triglyceride concentrations as well as reduced CHD odds but favorable effects on T2D risk have not yet been observed40,45,46. Here, ANGPTL3 is linked to type 2 diabetes mellitus.